Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026, Apr 2026, May 2026, Jun 2026 and Sep 2026.
- Largest single sale: $2.0M (21,086 shares) of Revolution Medicines, Inc. on Mar 25, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Chief Global Commercialization Officer | Mar 26, 2026 | Sep 28, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 25, 2026, Revolution Medicines, Inc.: sold 3,121 shares for $626K, under a disclosed plan; 3,121 shares acquired by exercising options. 1 filing: 1
- Sep 24, 2026, Revolution Medicines, Inc.: sold 587 shares for $117K, under a disclosed plan. 1 filing: 1
- Sep 18, 2026, Revolution Medicines, Inc.: sold 1,764 shares for $347K, under a disclosed plan. 1 filing: 1
- Sep 16, 2026, Revolution Medicines, Inc.: sold 1,774 shares for $353K, under a disclosed plan. 1 filing: 1
- Sep 10, 2026, Revolution Medicines, Inc.: sold 15,448 shares for $3.2M, under a disclosed plan; 9,363 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.